What is the next earnings date for HEPA stock?
HEPION PHARMACEUTICALS INC (HEPA) will report earnings on 2025-08-11.
HEPION PHARMACEUTICALS INC (HEPA) Forecast, Price Target & Analyst Ratings
NASDAQ:HEPA • US4268974015
Current stock price
0.318 USD
-0.07 (-18.79%)
At close:
0.1748 USD
-0.14 (-45.03%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for HEPION PHARMACEUTICALS INC (HEPA).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of $0.32 to mean target of N/A, Based on 7 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.86%
HEPA was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about HEPA.
In the previous month the buy percentage consensus was at a similar level.
HEPA was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2023-12-07 | Brookline Capital | Downgrade | Buy -> Hold |
| 2022-02-28 | Cantor Fitzgerald | Initiate | Overweight |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Aug 11, 2025
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates 2025 - 2031
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A 104.07% | N/A 52.99% | N/A 35.94% | |||||||||||
| EBITDA YoY % growth | -13.94M | -20.79M -49.14% | -20.99M -0.96% | -14.57M 30.59% | -7.74M 46.88% | -20.12M -159.95% | -30.31M -50.65% | -43.54M -43.65% | -45.191M -3.79% | -19.316M 57.26% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -13.96M | -20.81M -49.07% | -21.02M -1.01% | -14.59M 30.59% | -7.77M 46.74% | -20.15M -159.33% | -30.4M -50.87% | -43.62M -43.49% | -45.258M -3.76% | -19.347M 57.25% | N/A -330.74% | N/A -10.77% | N/A -96.69% | N/A 29.94% | N/A 24.46% | N/A 62.21% | N/A | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A 94.77% | -2,530.00 51.22% | N/A 82.26% | -590.00 -31.46% | -616.00 -4.41% | N/A 98.11% | N/A 54.51% | N/A -24.04% | N/A 1.71% | N/A 25.87% | N/A 24.47% | N/A 63.66% | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
25.77%
EPS Next 5 Year
14.78%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A